๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Su1292 Biomarker Panel for Prediction of Mucosal Healing in Patients With Crohn's Disease Under Infliximab Therapy

โœ Scribed by de Bruyn, Magali; Bessissow, Talat; Billiet, Thomas; Cleynen, Isabelle; Kirkland, Richard; Liu, Xinjun; Hauenstein, Scott; Drake, Katherine; Singh, Sharat; Ferrante, Marc; Rutgeerts, Paul J.; Van Assche, Gert A.; Arijs, Ingrid; Opdenakker, Ghislain; Vermeire, Severine


Book ID
122113406
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
488 KB
Volume
146
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Mucosal healing predicts long-term outco
โœ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert V ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 395 KB ๐Ÿ‘ 2 views

Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients